Recent Updates — PETV
PetVivo Holdings, Inc. announced that Diane Levitan resigned from the Board of Directors effective September 22, 2026, citing no disagreements with company operations. The Board appointed Jaime K. Pickett to fill the vacancy, maintaining the board size at six directors. Dr. Pickett brings over 20 years of veterinary healthcare and executive leadership experience, including roles as CEO of Hannah Pet Hospitals and Chief Medical Officer of EQUUSIR USA. She will serve until the next annual meeting and receive standard non-employee director compensation prorated for her period of service. PetVivo Holdings is an emerging biomedical device company focused on developing, manufacturing, and commercializing innovative medical devices, biomaterials, and therapeutics for companion animals.
PetVivo Holdings, Inc. announced that Joseph Jasper resigned from the Board of Directors effective September 22, 2026, citing no disagreements with company operations. The Board appointed Michael K. Handley as a director to fill the vacancy, maintaining the board size at six members. Mr. Handley brings over 25 years of life sciences experience, including capital raising and product commercialization in biotechnology and medical devices. PetVivo Holdings is an emerging biomedical device company focused on developing and commercializing innovative medical devices, biomaterials, and therapeutics for companion animals and human health.
PetVivo Holdings, Inc. entered into a Termination and Settlement Agreement with VetStem, Inc., effective July 24, 2026, to terminate their Exclusive License and Supply Agreement for the PrecisePRP® product line. The parties mutually released all claims and extinguished outstanding financial obligations, including invoices and royalties. PetVivo’s sole remaining obligation is an aggregate cash payment of $75,000, split into a $50,000 payment within 14 days and a $25,000 payment within 30 business days. Remaining PrecisePRP® inventory transfers to VetStem, subject to reconciliation if quantities fall below agreed minimums. The warrant held by VetStem for 250,000 shares remains outstanding. PetVivo Holdings operates in the biomedical device industry, manufacturing and commercializing medical devices and therapeutics for companion animals.